Ranolazine | South Africa Drug Approvals | Medicines Control Council | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Ranolazine
South Africa

Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

Contact Supplier

ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

Contact Supplier

Ever Pharma, highly specialized CDMO in producing complex injectables including high potency & controlled substances, suspensions, etc.

Contact Supplier

PharmaCompass Sponsored Ads

Contact Supplier

With Virupaksha, you get a quality product with on-time delivery.

Contact Supplier

LEBSA- Your strategic API source for niche molecules.

Contact Supplier

Ranolazine

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

61 API Suppliers, 28 USDMF, 17 EU WC, 2 KDMF, 22 NDC API, 38 Listed Suppliers, $ API Reference Price

61 API Suppliers
28 USDMF
17 EU WC
2 KDMF
22 NDC API
38 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

INTERMEDIATES

21 Intermediate Suppliers

21 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

111 FDF Dossiers, 56 FDA Orange Book, 28 Europe, 2 Canada, 3 South Africa, 22 Listed Dossiers

111 FDF Dossiers
56 FDA Orange Book
28 Europe
2 Canada
3 South Africa
22 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET, EXTENDED RELEASE;ORAL - 1GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, GRANULES, EXTENDED RELEASE;ORAL - 1GM, GRANULES, EXTENDED RELEASE;ORAL - 500MG

TABLET, EXTENDED RELEASE;ORAL - 1GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, EXTENDED RELEASE;ORAL - 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
GRANULES, EXTENDED RELEASE;ORAL - 1GM
GRANULES, EXTENDED RELEASE;ORAL - 500MG

RELATED EXCIPIENT COMPANIES

2 Evonik, 1 SPI Pharma, 4 DKSH, 2 Faran Shimi Pharmaceutical, 3 Gangwal Healthcare, 4 Nanjing Well Pharmaceutical, 1 ACG Worldwide, 2 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 6 BASF, 1 Clariant, 13 Corel Pharma Chem, 4 DFE Pharma, 10 Gangwal Chemicals, 11 Ideal Cures Pvt Ltd, 31 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 10 Microlex e.U, 1 Nanjing Bold Chemical, 2 Novo Excipients, 1 Pharmatrans-Sanaq, 2 Pluviaendo, 2 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 9 Roquette, 12 Seppic, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 10 Sigachi Industries, 2 The Dow Chemical Company, 1 Valens Pharmachem, 2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

64 Coating Systems & Additives, 41 Fillers, Diluents & Binders, 31 Controlled & Modified Release, 15 Thickeners and Stabilizers, 14 Solubilizers, 13 Direct Compression, 13 Film Formers & Plasticizers, 12 Lubricants & Glidants, 10 Granulation, 9 Parenteral, 8 Co-Processed Excipients, 7 Topical, 6 Rheology Modifiers, 6 Disintegrants & Superdisintegrants, 6 Taste Masking, 5 Emulsifying Agents, 5 Empty Capsules, 5 API Stability Enhancers, 4 Vegetarian Capsules, 4 Coloring Agents, 3 Chewable & Orodispersible Aids, 3 Surfactant & Foaming Agents

64 Coating Systems & Additives
41 Fillers, Diluents & Binders
31 Controlled & Modified Release
15 Thickeners and Stabilizers
14 Solubilizers
13 Direct Compression
13 Film Formers & Plasticizers
12 Lubricants & Glidants
10 Granulation
9 Parenteral
8 Co-Processed Excipients
7 Topical
6 Rheology Modifiers
6 Disintegrants & Superdisintegrants
6 Taste Masking
5 Emulsifying Agents
5 Empty Capsules
5 API Stability Enhancers
4 Vegetarian Capsules
4 Coloring Agents
3 Chewable & Orodispersible Aids
3 Surfactant & Foaming Agents

DIGITAL CONTENT

26 News #PharmaBuzz

26 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 25 Regulatory FDF Prices, 8 Annual Reports

1 US Medicaid Prescriptions
25 Regulatory FDF Prices
8 Annual Reports

MARKET PLACE

17 APIs, 2 FDF Dossiers

17 APIs
2 FDF Dossiers

PATENTS & EXCLUSIVITIES

4 US Patents

4 US Patents

REF. STANDARDS & IMPURITIES

4 USP, 10 Others

4 USP
10 Others

ANALYTICAL

2 BioAnalytical Methods

2 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 82 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

3 All

01 3Lebasi Pharmaceuticals CC

filter Active Ingredients Reset all filters

3 All

01 3Ranolazine

filter Dosage Form Reset all filters

3 All

01 3SRT

filter Brand Name Reset all filters

3 All

01 1Ranexa 375 mg

02 1Ranexa 500 mg

03 1Ranexa 750 mg

List of Suppliers

Product Main Page

01

Lebasi Pharmaceuticals CC

AAN

Not Confirmed

Lebasi Pharmaceuticals CC

AAN

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Originator

Registration Country : South Africa

Brand Name : Ranexa 375 mg

Dosage Form : SRT

Dosage Strength : 375mg

Packaging : 60X1mg

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Lebasi Pharmaceuticals CC

AAN

Not Confirmed

Lebasi Pharmaceuticals CC

AAN

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Originator

Registration Country : South Africa

Brand Name : Ranexa 500 mg

Dosage Form : SRT

Dosage Strength : 500mg

Packaging : 60X1mg

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Lebasi Pharmaceuticals CC

AAN

Not Confirmed

Lebasi Pharmaceuticals CC

AAN

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Originator

Registration Country : South Africa

Brand Name : Ranexa 750 mg

Dosage Form : SRT

Dosage Strength : 750mg

Packaging : 60X1mg

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!